Omar Husseini, MD
Cardiovascular Disease · Munster, INNPI 1467740894
Payments from drug & device makers
Across 425 payments — averaging $154.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lantheus Medical Imaging, Inc.$42K
- Edwards Lifesciences$14K
- Abbott$2K
- Boston Scientific$2K
- Novartis$1K
- Amgen$524
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lantheus Medical Imaging, Inc. | 46 | $42,250 |
| Edwards Lifesciences | 49 | $14,108 |
| Abbott | 33 | $2,443 |
| Boston Scientific | 22 | $2,114 |
| Novartis | 91 | $1,276 |
| Amgen | 28 | $524 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $504 |
| Johnson & Johnson | 21 | $305 |
| Merck | 18 | $262 |
| Boehringer Ingelheim | 10 | $182 |
| Pfizer | 10 | $173 |
| AstraZeneca | 12 | $171 |
| Inspire Medical Systems, Inc. | 4 | $159 |
| Regeneron Healthcare Solutions, Inc. | 6 | $126 |
| Mylan Specialty L.p. | 1 | $125 |
| Biosense Webster, Inc. | 2 | $120 |
| Penumbra, Inc. | 1 | $117 |
| E.r. Squibb & Sons, L.L.C. | 7 | $106 |
| Sanofi-aventis U.S. LLC | 6 | $102 |
| Chiesi USA, Inc. | 6 | $95 |
| Atricure, Inc. | 3 | $75 |
| Scpharmaceuticals Inc. | 3 | $69 |
| Novo Nordisk | 2 | $50 |
| Actelion Pharmaceuticals US, Inc. | 2 | $39 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $38 |
| Cvrx, Inc. | 2 | $34 |
| Bolton Medical Inc | 1 | $32 |
| Lundbeck LLC | 2 | $29 |
| Bayer | 1 | $29 |
| Tactile Systems Technology Inc | 1 | $27 |
| Gilead | 2 | $26 |
| Astellas Pharma US Inc | 1 | $22 |
| Argon Medical Devices, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Vifor Pharma, Inc. | 1 | $11 |
How this compares
$65,795 in reported general payments places this provider in the 85th percentile of 408 cardiovascular disease providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Munster
- Ravi BhagwatMunster$2.2M
- Mohan KesaniMunster$1.2M
- Wail AsfourMunster$736K
- John McGintyRichmond$3.7M
- Steven SteinhublLafayette$2.4M
- Vijay MehtaElkhart$925K
- William CollisFort Wayne$842K
- Atul ChughIndianapolis$775K
- Noel DasguptaIndianapolis$744K
- Vijay RaoIndianapolis$706K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.